Work

Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

Year: 2011

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-011-9670-0

Authors: Simona Lapusan, Maria B. Vidriales, Xavier Thomas, Stephane de Botton, Anne Vekhoff, Ruoping Tang, Charles Dumontet, Rodica Morariu-Zamfir, John M. Lambert, Marie-Laure Ozoux, Philippe Poncelet, Jesus F. San Miguel, Ollivier Legrand, Daniel J. DeAngelo, Francis J. Giles, Jean-Pierre Marie

Institutions: Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Complejo Hospitalario de Salamanca, Hôpital Edouard Herriot, Institut Gustave Roussy, Sanofi (France), Université Pierre-et-Marie-Curie, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1999212901

FWCI: 6.07

Cites: 17

Cited by: 108

Related to: 10